Genedata Joins Japanese Research Initiative For Metastatic Biomarkers

Swiss-based research informatics provider Genedata announced its collaboration with Tokyo Medical University, AMR Inc., and Leica Microsystems in a proteomics research initiative aiming at the identification of metastatic biomarkers for the discovery and validation of new protein drug targets. In the project, proteins extracted from lung and endocrine carcinoma FFPE tissue collections are analyzed using state-of-the-art MS-based proteomic methodologies. [click link for full article]

More: continued here

Filed under: Pharma Industry on November 18th, 2007